RAB11 family interacting protein 1 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored RAB11FIP1P1 profile across patient tissues and cancer cell-line models. RAB11FIP1P1 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, RAB11FIP1P1 is differentially expressed in 11, with the highest sampling consensus in UCEC. Additionally, RAB11FIP1P1 RNA expression shows 20,441 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight UCEC, and THYM as cancer lineages where RAB11FIP1P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RAB11FIP1P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RAB11FIP1P1 survival associations across molecular data types. RAB11FIP1P1 RNA expression shows survival associations in the most cancer types (24). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RAB11FIP1P1 RNA expression–survival associations across cancer types. High RAB11FIP1P1 expression shows unfavorable associations in UCEC, KIRC, THCA, KICH and UVM, but favorable associations in SKCM. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for RAB11FIP1P1 RNA expression.
This table summarizes RAB11FIP1P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in BRCA for RNA.
This table ranks reproducible tumor–normal expression differences for RAB11FIP1P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RAB11FIP1P1 shows lower tumor expression in UCEC and BRCA and higher tumor expression in CHOL, HNSC, LIHC and KIRP. The UCEC box plot shows higher RAB11FIP1P1 RNA expression in normal versus tumor tissue (log2 FC = −0.657, t-test p < 0.001).
This table shows molecular features associated with RAB11FIP1P1 in patient tissues and cancer cell lines. In patient samples, RAB11FIP1P1 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
